ArticleInternational journal of breast cancer2018

CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy.

Ashley J Schlafstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.